20
Participants
Start Date
April 15, 2025
Primary Completion Date
April 16, 2027
Study Completion Date
April 16, 2028
QL1706
5 mg/kg, IV infusion, Q3W (D1)
Chemotherapy
FAEV, EMA/EP, EMA/CO, or TP/TE.
RECRUITING
Peking Union Medical College Hospital, Beijing
Shengjing Hospital
OTHER
Obstetrics & Gynecology Hospital of Fudan University (Shanghai Red House Ob & Gyn Hospital)
UNKNOWN
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Henan Cancer Hospital
OTHER_GOV
Gansu Provincial Maternal and Child Health Care Hospital
OTHER
Dalian women and children's medical group
UNKNOWN
The First Affiliated Hospital of Xiamen University
OTHER
Sichuan Cancer Hospital and Research Institute
OTHER
Peking Union Medical College Hospital
OTHER